Rescue of streptomycin activity by piperine in Mycobacterium tuberculosis.

Future Microbiology
Leonora L CalsavaraKatiany R Caleffi-Ferracioli

Abstract

Aim: To evaluate the modulatory effect of piperine (PIP) on streptomycin (SM) activity in Mycobacterium tuberculosis (Mtb). Materials & methods: SM and PIP minimum inhibitory concentration (MIC) and combinatory activity were determined in Mtb H37Rv and in susceptible and resistant clinical isolates. Ethidium bromide accumulation assay and relative quantification of efflux pumps genes (rv1258c, rv1218c and rv2942), after SM and SM+PIP combination exposure, were also performed. Results: PIP concentration of 25 μg/ml (1/4× MIC) was able to inhibit efflux pumps activity, to modulate SM activity in Mtb, and conducted changes in the relative quantification of efflux pumps genes. Conclusion: SM+PIP combination was able to rescue the SM-susceptible MIC values in SM-resistant Mtb.

References

Jan 8, 1999·Molecular and Cellular Biochemistry·A KhajuriaK L Bedi
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·Juan-Carlos PalominoFrançoise Portaels
Jun 14, 2003·The Journal of Antimicrobial Chemotherapy·F C Odds
Jan 28, 2006·FEMS Microbiology Reviews·Edda De RossiGiovanna Riccardi
Aug 2, 2006·Biochemical and Biophysical Research Communications·Jacqueline PérezHoward E Takiff
Jan 8, 2010·Protein Science : a Publication of the Protein Society·Christine E CadeReza A Ghiladi
Jun 8, 2010·The Journal of Antimicrobial Chemotherapy·Sandeep SharmaInshad Ali Khan
Oct 6, 2010·Antimicrobial Agents and Chemotherapy·Meenakshi BalganeshUmender Sharma
Nov 19, 2010·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Marcos Abdo ArbexFernando Augusto Fiúza de Mello
Mar 12, 2011·The Journal of Antimicrobial Chemotherapy·Paula Aline Zanetti CampanerutRosilene Fressatti Cardoso
Aug 30, 2011·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Liliana RodriguesMiguel Viveiros
Mar 31, 2012·Bioorganic & Medicinal Chemistry·Barbara GröblacherFranz Bucar
Oct 3, 2013·Tuberculosis·Katiany R Caleffi-FerracioliRosilene F Cardoso
Feb 8, 2018·ACS Infectious Diseases·Samantha Wellington, Deborah T Hung
Jul 22, 2018·Tuberculosis·Laíse Adriane HegetoRosilene Fressatti Cardoso
Jan 17, 2019·Future Microbiology·Katiany R Caleffi-FerracioliFernando R Pavan
Jun 21, 2019·The Indian Journal of Medical Research·Atin SharmaRanjana Pathania
Sep 18, 2020·PLoS Biology·Nikos Fatsis-KavalopoulosDan I Andersson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.